RT Journal Article
SR Electronic
T1 Early postmortem brain MRI findings in COVID-19 non-survivors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.04.20090316
DO 10.1101/2020.05.04.20090316
A1 Coolen, Tim
A1 Lolli, Valentina
A1 Sadeghi, Niloufar
A1 Rovaï, Antonin
A1 Trotta, Nicola
A1 Taccone, Fabio Silvio
A1 Creteur, Jacques
A1 Henrard, Sophie
A1 Goffard, Jean-Christophe
A1 De Witte, Olivier
A1 Naeije, Gilles
A1 Goldman, Serge
A1 De Tiège, Xavier
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.04.20090316.abstract
AB Importance The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is considered to have potential neuro-invasiveness that might lead to acute brain disorders or contribute to respiratory distress in patients with coronavirus disease 2019 (COVID-19). Brain magnetic resonance imaging (MRI) data in COVID-19 patients are scarce due to difficulties to obtain such examination in infected unstable patients during the COVID-19 outbreak.Objective To investigate the occurrence of structural brain abnormalities in non-survivors of COVID-19 in a virtopsy framework.Design Prospective, case series study with postmortem brain MRI obtained early (<24h) after death.Setting Monocentric study.Participants From 31/03/2020 to 24/04/2020, consecutive decedents who fulfilled the following inclusion criteria were included: death <24 hours, SARS-CoV-2 detection on nasopharyngeal swab specimen, chest computerized tomographic (CT) scan suggestive of COVID-19, absence of known focal brain lesion, and MRI compatibility.Main Outcome(s) andMeasure(s) Signs of acute brain injury and MRI signal abnormalities along the olfactory tract and brainstem were searched independently by 3 neuroradiologists, then reviewed with neurologists and clinicians.Results Among the 62 patients who died from COVID-19 during the inclusion period, 19 decedents fulfilled inclusion criteria. Subcortical micro- and macro-bleeds (2 decedents), cortico-subcortical edematous changes evocative of posterior reversible encephalopathy syndrome (PRES, one decedent), and nonspecific deep white matter changes (one decedent) were observed. Asymmetric olfactory bulbs were found in 4 other decedents without downstream olfactory tract abnormalities. No brainstem MRI signal abnormality.Conclusions and Relevance Postmortem brain MRI demonstrates hemorrhagic and PRES-related brain lesions in non-survivors of COVID-19 that might be triggered by the virus-induced endothelial disturbances. SARS-CoV-2-related olfactory impairment seems to be limited to olfactory bulbs. The absence of brainstem MRI abnormalities does not support a brain-related contribution to respiratory distress in COVID-19.Question Is there common brain MRI abnormalities patterns in non-survivors of coronavirus disease 2019 ?Findings In a case series of 19 non-survivors of severe COVID-19 disease, early postmortem brain MRI demonstrated patterns evocative of intracranial vasculopathy in 4 decedents: subcortical micro- and macro-bleeds (2 decedents), cortico-subcortical edematous changes evocative of posterior reversible encephalopathy syndrome (PRES, one decedent), and nonspecific deep white matter changes (one decedent). Asymmetric olfactory bulbs were found in 4 other decedents but without downstream olfactory tract abnormalities.Meaning Postmortem brain MRI demonstrates hemorrhagic and PRES-related brain lesions in non-survivors of COVID-19 that might be triggered by virus-induced endothelial disturbances.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a special call "COVID-19" funded by the Université libre de Bruxelles, the Fonds Erasme (Brussels, Belgium) and the Fondation ULB (Brussels, Belgium). The PET-MR project at the CUB Hôpital Erasme and Université libre de Bruxelles is financially supported by the Association Vinçotte Nuclear (AVN, Brussels, Belgium). Gilles Naeije and Xavier De TiÈge are Postdoctorate Clinical Master Specialists at the Fonds de la Recherche Scientifique (FRS-FNRS, Brussels, Belgium).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request and if accepted by the Ethical Committee